Daptomycin and Ezetimibe Interaction

Drug interaction information between Daptomycin and Ezetimibe.

Daptomycin and Ezetimibe have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Daptomycin and Ezetimibe. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Daptomycin

Lipopeptide Antibiotic

Drug B

Ezetimibe

Cholesterol Absorption Inhibitor

How They Interact

Both of these medicines can cause muscle damage as a side effect. Taking them together makes this risk even higher and can lead to a serious condition where muscle tissue breaks down.

FDA Label Information

Daptomycin Clinical Impact: Cases of rhabdomyolysis have been reported with simvastatin administered with daptomycin. Both ezetimibe and simvastatin and daptomycin can cause myopathy and rhabdomyolysis when given alone and the risk of myopathy and rhabdomyolysis may be increased by coadministration. Intervention: If treatment with daptomycin is required, consider temporarily suspending ezetimibe and simvastatin during the course of daptomycin treatment.

Frequently Asked Questions

What SPL severity band is on file for Daptomycin + Ezetimibe?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Ezetimibe has 25 labeled pairs on file vs Daptomycin's 3. In the moderate band specifically: Daptomycin has 3 (also Ezetimibe/Simvastatin, Simvastatin); Ezetimibe has 4 (also Colchicine, Niacin, Simvastatin).

What mechanism field is on file for Daptomycin and Ezetimibe?

Both of these medicines can cause muscle damage as a side effect. Taking them together makes this risk even higher and can lead to a serious condition where muscle tissue breaks down.

Ezetimibe carries more major-labeled pairs than Daptomycin

SPL source-record counts only. This page's band is moderate · classes on file: Daptomycin (Lipopeptide Antibiotic); Ezetimibe (Cholesterol Absorption Inhibitor).

Ezetimibe has 8 major-labeled pairs vs Daptomycin's 0. This page itself is in the moderate band, not the major band.

Daptomycin

0 major · 3 moderate · 0 minor · 3 total

Ezetimibe

8 major · 4 moderate · 13 minor · 25 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.